Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Lin

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
Annals of the Rheumatic Diseases|October 31, 2007
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitisJ C Davis, D M van der Heijde, J Braun, et al.
Arthritis and Rheumatism|August 29, 2009
Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritisE H Giannini, N T Ilowite, D J Lovell, et al.
Clinical Pharmacology and Therapeutics|June 18, 2015
Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney DiseaseP-C Wu, C-J Wu, C-J Lin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 5, 2021
[Energy metabolism characteristic with risk of secondary bacterial infection in patients with hepatitis B virus-related chronic liver disease]S L Lin, M H Lin, X M Wang, et al.
Molecular and Cellular Biology|January 7, 1998
Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cellsE Sancho, M R Vilá, L Sánchez-Pulido, et al.
Archives of Disease in Childhood|July 18, 2009
The association of clinical findings and exposure profiles with melamine associated nephrolithiasisI J Wang, Y N Wu, W C Wu, et al.
Nature Biotechnology|January 27, 1999
Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivoK B Low, M Ittensohn, T Le, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Annals of the Rheumatic Diseases|October 31, 2007
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitisJ C Davis, D M van der Heijde, J Braun, et al.
Arthritis and Rheumatism|August 29, 2009
Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritisE H Giannini, N T Ilowite, D J Lovell, et al.
Clinical Pharmacology and Therapeutics|June 18, 2015
Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney DiseaseP-C Wu, C-J Wu, C-J Lin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 5, 2021
[Energy metabolism characteristic with risk of secondary bacterial infection in patients with hepatitis B virus-related chronic liver disease]S L Lin, M H Lin, X M Wang, et al.
Molecular and Cellular Biology|January 7, 1998
Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cellsE Sancho, M R Vilá, L Sánchez-Pulido, et al.
Archives of Disease in Childhood|July 18, 2009
The association of clinical findings and exposure profiles with melamine associated nephrolithiasisI J Wang, Y N Wu, W C Wu, et al.
Nature Biotechnology|January 27, 1999
Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivoK B Low, M Ittensohn, T Le, et al.
Pageof 22